Payment overview · 2025
General Payments
$110,633.85
107 reported records · 16 companies
Healthcare provider profile · identity verified
Erin Heather Murphy, MD
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · CHARLOTTE, NC · NPI 1447454210
Verified facts
What the public records show
CMS Open Payments records show Erin Heather Murphy, MD received $110,633.85 in general payments during 2025 across 107 reported records.
Philips North America LLC accounted for 53.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 34 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Philips North America LLC | Unresolved — no canonical attribution shown | $59,113.56 | 53.4% | 22 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $21,814.26 | 19.7% | 21 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $13,659.04 | 12.3% | 10 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$12,896.76 | 11.7% | 13 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $1,014.10 | 0.9% | 10 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $685.04 | 0.6% | 11 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $527.71 | 0.5% | 9 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $247.42 | 0.2% | 2 | 2025 |
| Veryan Medical Incorporated | Unresolved — no canonical attribution shown | $160.36 | 0.1% | 1 | 2025 |
| Mercator MedSystems, Inc. | Unresolved — no canonical attribution shown | $150.95 | 0.1% | 1 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $109.17 | 0.1% | 2 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $102.56 | 0.1% | 1 | 2025 |
| VentureMed Group, Inc. | Unresolved — no canonical attribution shown | $53.96 | 0.1% | 1 | 2025 |
| Inquis Medical, Inc. | Unresolved — no canonical attribution shown | $38.34 | 0.0% | 1 | 2025 |
| CMS Imaging, Inc. | Unresolved — no canonical attribution shown | $32.99 | 0.0% | 1 | 2025 |
| Avantec Vascular Corporation | Unresolved — no canonical attribution shown | $27.63 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $88,501.89 | 23 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,845.00 | 6 |
| Food and Beverage | $4,600.08 | 68 |
| Travel and Lodging | $3,711.88 | 9 |
| Honoraria | $975.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| IGT Devices Undivided Normalized: igt devices undivided |
Device | Philips North America LLC | $57,836.38 | 16 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $14,871.02 | 8 | 2025 |
Source payment records
|
|||||
| MYNX CONTROL VENOUS Normalized: mynx control venous |
Device | CORDIS US CORP. | $13,385.26 | 7 | 2025 |
Source payment records
|
|||||
| ABRE Normalized: abre |
Device | Medtronic, Inc. | $11,551.66 | 7 | 2025 |
Source payment records
|
|||||
| Varithena Administration Pack Normalized: varithena administration pack |
Device | Boston Scientific Corporation | $5,276.50 | 6 | 2025 |
Source payment records
|
|||||
| JETSTREAM SC Normalized: jetstream sc |
Device | Boston Scientific Corporation | $1,489.73 | 5 | 2025 |
Source payment records
|
|||||
| US EQ Undivided Normalized: us eq undivided |
Device | Philips North America LLC | $975.00 | 1 | 2025 |
Source payment records
|
|||||
| Venovo Normalized: venovo |
Device | Bard Peripheral Vascular, Inc. | $686.53 | 6 | 2025 |
Source payment records
|
|||||
| CLOSUREFAST Normalized: closurefast |
Device | Medtronic, Inc. | $675.00 | 1 | 2025 |
Source payment records
|
|||||
| VENASEAL Normalized: venaseal |
Device | Medtronic, Inc. | $570.22 | 2 | 2025 |
Source payment records
|
|||||
| Product in Development Normalized: product in development |
Device | W. L. Gore & Associates, Inc. | $350.71 | 5 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $264.44 | 3 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $264.44 | 3 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $247.42 | 2 | 2025 |
Source payment records
|
|||||
| GORE DRYSEAL FLEX Introducer Sheath Normalized: gore dryseal flex introducer sheath |
Device | W. L. Gore & Associates, Inc. | $177.00 | 4 | 2025 |
Source payment records
|
|||||
| SELUTION SLR PTCA Normalized: selution slr ptca |
Device | CORDIS US CORP. | $172.37 | 1 | 2025 |
Source payment records
|
|||||
| Venclose Maven Catheter Normalized: venclose maven catheter |
Device | Bard Peripheral Vascular, Inc. | $171.97 | 3 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $162.74 | 2 | 2025 |
Source payment records
|
|||||
| BioMimics 3D Vascular Stent System Normalized: biomimics 3d vascular stent system |
Device | Veryan Medical Incorporated | $160.36 | 1 | 2025 |
Source payment records
|
|||||
| IV Other Normalized: iv other |
Device | Philips North America LLC | $158.06 | 2 | 2025 |
Source payment records
|
|||||
| Leapfrog Micro-Infusion Device Normalized: leapfrog micro infusion device |
Device | Mercator MedSystems, Inc. | $150.95 | 1 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $123.90 | 2 | 2025 |
Source payment records
|
|||||
| General - Thrombectomy Normalized: general thrombectomy |
Device | Boston Scientific Corporation | $122.18 | 1 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $102.56 | 1 | 2025 |
Source payment records
|
|||||
| SELUTION SLR PTA Normalized: selution slr pta |
Device | CORDIS US CORP. | $101.41 | 2 | 2025 |
Source payment records
|
|||||
| Peripheral Vascular Undivided Normalized: peripheral vascular undivided |
Device | Philips North America LLC | $89.64 | 2 | 2025 |
Source payment records
|
|||||
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $86.95 | 1 | 2025 |
Source payment records
|
|||||
| RUBY Coil Normalized: ruby coil |
Device | Penumbra, Inc. | $60.92 | 1 | 2025 |
Source payment records
|
|||||
| VENOUS WALLSTENT Normalized: venous wallstent |
Device | Boston Scientific Corporation | $54.83 | 1 | 2025 |
Source payment records
|
|||||
| Coronary Other Normalized: coronary other |
Device | Philips North America LLC | $54.48 | 1 | 2025 |
Source payment records
|
|||||
| FLEX Vessel Prep System Normalized: flex vessel prep system |
Device | VentureMed Group, Inc. | $53.96 | 1 | 2025 |
Source payment records
|
|||||
| Real Immersive System Normalized: real immersive system |
Device | Penumbra, Inc. | $48.25 | 1 | 2025 |
Source payment records
|
|||||
| VENACORE THROMBECTOMY CATHETER Normalized: venacore thrombectomy catheter |
Device | Stryker Corporation | $47.01 | 3 | 2025 |
Source payment records
|
|||||
| Aventus Normalized: aventus |
Device | Inquis Medical, Inc. | $38.34 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Diazepam | Diazepam | 12 | 12 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $110,633.85 · 107 records | Philips North America LLC | ABRE, ARTIX MT, AURYON LASER SYSTEM 100-120 VAC, Aventus, BioMimics 3D Vascular Stent System, CGuard Prime Carotid Stent System, CLOSUREFAST, CLOTTRIEVER BOLD CATHETER, CT THROMBECTOMY SYSTEM KIT, Coronary Other, FLEX Vessel Prep System, FLOWTRIEVER CATHETER, S, GORE DRYSEAL FLEX Introducer Sheath, General - Therapies, General - Thrombectomy, IGT Devices Undivided, IV Other, JETSTREAM SC, LIMFLOW SYSTEM, Leapfrog Micro-Infusion Device, MYNX CONTROL VENOUS, Peripheral Vascular Undivided, Product in Development, RUBY Coil, Real Immersive System, SELUTION SLR PTA, SELUTION SLR PTCA, US EQ Undivided, VENACORE THROMBECTOMY CATHETER, VENASEAL, VENOUS WALLSTENT, Varithena Administration Pack, Venclose Maven Catheter, Venovo | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error